CMV Reactivations During and After Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience.

Prevymis (letermovir) - Merck (MSD)

CMV Reactivations During and After Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience. (PubMed, Mediterr J Hematol Infect Dis) - Nov 14, 2025 - No abstract available
Journal • Bone Marrow Transplantation • Transplantation

http://www.ncbi.nlm.nih.gov/pubmed/41235027

Alessandra Algarotti; Alessandro Rambaldi; Anna Grassi; Benedetta Rambaldi; Chiara Pavoni; Edoardo Olivari; Federico Lussana; Gianluca Cavallaro; Giuliana Rizzuto; Maria Caterina Micò; Maria Chiara Finazzi

Nov 14, 2025